The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel.

Abstract
The bioavailabilities in humans of flufenamic acid (1) [an antiinflammatory agent used in the treatment of rheumatoid arthritis] from a commercial aluminum flufenamate (2) tablet and 1 capsule were estimated by measuring urinary excretion of 1 and its metabolites fluorometrically. The dissolution rates of 1 from both dosage forms were also determined. The effects of concomitant intake of food or antacid on the bioavailabilities from the 2 tablet and the 1 capsule were investigated. The extent of 1 bioavailability from the 2 tablet was < 30% of that from the 1 capsule. Dissolution tests suggested that the low bioavailability of 1 from 2 tablet resulted from the extremely slow release of 1 from the 2 complex. Intake of a standard meal retarded 1 absorption from 1 capsule but did not affect that from the 2 tablet. Ingestion of dried aluminum hydroxide gel granules had little effect on 1 bioavailability from the 1 capsule.

This publication has 1 reference indexed in Scilit: